Belimumab (BEL) Improves Renal Outcomes in Active Lupus Nephritis (LN): A Phase 3 Randomized, Placebo (PBO)-Controlled Trial
Rovin B, Houssiau F, Furie R, Malvar A, Teng Y, Mok C, Contreras G, Yu X, Dolff S, Ji B, Roth D, Kleoudis C, Makowiak S, Madan A, Gilbride J, Green Y. Belimumab (BEL) Improves Renal Outcomes in Active Lupus Nephritis (LN): A Phase 3 Randomized, Placebo (PBO)-Controlled Trial. Journal Of The American Society Of Nephrology 2020, 31: 54-54. DOI: 10.1681/asn.20203110s154a.Peer-Reviewed Original Research